Certified Yusho victim
Conditions
Interventions
2.5 g of Keisi-bukuryogan (Tsumura) is administered t.i.d every before or between meals until 3 months after the enrollment.
Sponsors
Department of Dermatology, Graduate School of Medical Sciences, Kyushu University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed as Yusho according to Yusho diagnostic criteria, the Study Group for "Yusho". 2) Patients providing written informed consent. 3) Patients who are able to take Kampo medicine. 4) Patients with more than 20 years.
Exclusion criteria
Exclusion criteria: 1) Women who have pregnancy, are nursing, or are likely to become pregnant. 2) Patients who are taking other Kampo medicines. Patients who have 4 weeks washout period for attending the study are eligible. 3) Any other patients who are regarded as unsuitable for this study by the investigators because of such as serious complication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score (peripheral nerve: pain, numbness, skin; acne, blotch, respiratory; cough, sputum, malaise) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. QOL (Quality Of Life) quantitatively evaluated by SF-36. 2. Oxidative stress marker value s and anti-oxidative stress marker values. 1. Safety during treatment period. | — |
Countries
Japan
Contacts
Public ContactChikage Mitoma
Kyushu University Hospital Research and Clinical Center for Yusho and Dioxin
Outcome results
None listed